Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naiem Issa

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology|February 4, 2025
Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work?Ayman Grada, Naiem Issa
Journal of Drugs in Dermatology : JDD|January 6, 2023
Supplement Individual Article: A Reappraisal of Fixed-Combination Halobetasol Propionate and Tazarotene for the Treatment of Psoriasis: Biological Underpinnings, Therapeutic Mechanisms, and Economic ConsiderationsNaiem Issa, Leon Kircik
Journal of Drugs in Dermatology : JDD|December 5, 2022
Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case ReportEric Gutierrez, Naiem Issa, Barry Resnik
JAAD Case Reports|October 27, 2021
Mosaic <i>TP63</i> variant and associated ectodermal dysplasia featuresVivien Chen, Naiem Issa, Fernanda Bellodi Schmidt
Journal of Drugs in Dermatology : JDD|December 5, 2022
SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of TazaroteneNaiem Issa, Zoe Draelos, Emil Tanghetti, et al.
Current Dermatology Reports|August 15, 2017
The Role of the Skin and Gut Microbiome in Psoriatic DiseaseDi Yan, Naiem Issa, Ladan Afifi, et al.
Plos One|December 18, 2018
Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cellsSara Maimouni, Naiem Issa, Selina Cheng, et al.
The Journal of Clinical and Aesthetic Dermatology|March 13, 2025
Achievement of Optimal Treatment Targets with Oral Janus Kinase Inhibition in Elderly Patients with Atopic Dermatitis: A Real-world, Multicenter, Retrospective StudyDiego Ruiz Dasilva, Noelle Desir, Iain Noel Encarnacion, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Dermatology and Therapy|June 27, 2026
Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc AnalysisStephen Weidinger, Kristian Reich, Naiem Issa, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|February 4, 2025
Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work?Ayman Grada, Naiem Issa
Journal of Drugs in Dermatology : JDD|January 6, 2023
Supplement Individual Article: A Reappraisal of Fixed-Combination Halobetasol Propionate and Tazarotene for the Treatment of Psoriasis: Biological Underpinnings, Therapeutic Mechanisms, and Economic ConsiderationsNaiem Issa, Leon Kircik
Journal of Drugs in Dermatology : JDD|December 5, 2022
Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case ReportEric Gutierrez, Naiem Issa, Barry Resnik
JAAD Case Reports|October 27, 2021
Mosaic <i>TP63</i> variant and associated ectodermal dysplasia featuresVivien Chen, Naiem Issa, Fernanda Bellodi Schmidt
Journal of Drugs in Dermatology : JDD|December 5, 2022
SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of TazaroteneNaiem Issa, Zoe Draelos, Emil Tanghetti, et al.
Current Dermatology Reports|August 15, 2017
The Role of the Skin and Gut Microbiome in Psoriatic DiseaseDi Yan, Naiem Issa, Ladan Afifi, et al.
Plos One|December 18, 2018
Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cellsSara Maimouni, Naiem Issa, Selina Cheng, et al.
The Journal of Clinical and Aesthetic Dermatology|March 13, 2025
Achievement of Optimal Treatment Targets with Oral Janus Kinase Inhibition in Elderly Patients with Atopic Dermatitis: A Real-world, Multicenter, Retrospective StudyDiego Ruiz Dasilva, Noelle Desir, Iain Noel Encarnacion, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Dermatology and Therapy|June 27, 2026
Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc AnalysisStephen Weidinger, Kristian Reich, Naiem Issa, et al.
Pageof 2